carcinoma

(redirected from neuroendocrine carcinoma)
Also found in: Dictionary, Thesaurus, Medical.

carcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

carcinoma

[‚kärs·ən′ō·mə]
(medicine)
A malignant epithelial tumor.

carcinoma

Pathol
1. any malignant tumour derived from epithelial tissue
2. another name for cancer
References in periodicals archive ?
Keywords: SCNEC: Small cell neuroendocrine carcinoma, Gy: Grey, APUD: Amine precursor uptake and decarboxylase System.
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
An unusual case of primary small cell neuroendocrine carcinoma of the breast.
Outcome and management are different for each tumor type, but surgery is generally used for all, with chemotherapy added for the atypical carcinoid and small or large cell neuroendocrine carcinomas.
Non-small cell neuroendocrine carcinomas are rare low grade tumors with prognosis better than ONB.
This case report describes a healthy, vital 52-year old-man with no complaints of dyspnoe, fatigue or loss of weight with a cT1aN3M1b neuroendocrine carcinoma of the lung, stage IV which presented itself as a palpable testicular tumour.
22%) each of neuroendocrine carcinoma, carcinosarcoma and epithelial Myoepithelial carcinoma.
Positive immunoreactivity to at least two markers is required for the diagnosis of a neuroendocrine carcinoma (8, 9).
6) Prior to its identification as a separate disease entity, LCNEC was grouped with small cell neuroendocrine carcinoma.
Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature.
Researchers discuss such aspects as cytological tools to help the diagnosis and management, distinguishing small cell carcinoma from large cell neuroendocrine carcinoma, the impact of tumor motion in the three-dimensional radiotherapy of lung cancer, clinical presentation and diagnostic modalities, whether the curative thoracic radiotherapy is cost-effective in extensive-state small cell lung cancer, optimal treatment of small cell lung cancer, and therapeutic strategy for primary and pure neuroendocrine carcinoma of the bladder.
It would also have been possible to use either radionucleotide Octreotide or Meta-iodobenzylguanidine (MIBG) scanning to try and improve the accuracy of diagnosis of neuroendocrine carcinoma.